Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: Hum - You Need To See This

Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.

Barchart

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

MarketBeat

Is Humana Stock Outperforming the Nasdaq?

Humana has rallied the Nasdaq Composite over the past year, and analysts remain moderately bullish about the stock’s outlook.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Humana Stock Outlook: Is Wall Street Bullish or Bearish?

Humana has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.

Barchart

Humana Surges Above 50-Day MA. Should You Buy HUM Stock on CMS Rate Changes Here?

Humana shares rally as CMS finalized 2027 Medicare Advantage payments rate at 2.48%. Valuation and options pricing warrant owning HUM shares in 2026.

Barchart

Is Humana Stock Underperforming the S&P 500?

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Humana Stock Will Climb or Sink?

Humana has notably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Should You Buy the Dip in These 2 Dividend Stocks?

Tighter Medicare Advantage payment rates are testing two established health insurers, with CVS Health offering a safer dividend entry at 28% upside and 3% yield while Humana's 36% year-over-year decline creates a riskier but potentially stronger bounce-back opportunity if profitability stabilizes faster than the market expects.

Barchart

These Are the 3 Top Oversold S&P 500 Stocks. Should You Buy the Dip?

Abbott, Roper, and Humana are three blue-chip oversold stocks with significant upside potential for shareholders in January 2026.

Barchart

What to Expect From Humana’s Next Quarterly Earnings Report

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

Barchart

Humana Stock Is Nearly 20% Off Its YTD Highs. Can Mark Cuban Change That?

Mark Cuban is allegedly looking to partner with Humana on pharmacy offerings.

Barchart

Adding yet more needless features, Discord joins the 'wrapped' crew with a yearly stat recap called Checkpoint

Can it not?

PC Gamer

How Is Humana Stock Performance Compared to Other Healthcare Services Stocks?

Humana stock has underperformed compared to the healthcare services group, but analysts remain fairly bullish about its prospects.

Barchart

Is Wall Street Bullish or Bearish on Humana Stock?

Although Humana has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Stocks Rebound on Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.42%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.12%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.41%. December E-mini S&P futures (ESZ25 ) are up +0.39%, and December E-mini Nasdaq futures...

Benzinga

Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles

Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82.

Barchart

Stock Indices Recover Following Sharp Sell-Off on Tuesday

The S&P 500 Index ($SPX ) (SPY ) today is up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. Some weaker-than-expected earnings are weighing on technology stocks. Super Micro Computer is down more...

Barchart

What to Expect From Humana's Q3 2025 Earnings Report

Humana is scheduled to release its fiscal third-quarter earnings next month, and analysts project a double-digit earnings fall.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

S&P 500, Nasdaq 100, Dow, Russell 2000 All Soar To Record Highs: What's Moving Markets Friday

Another historic session is unfolding on Wall Street, where every major index surged to new records by midday trading on Friday, even as Washington's shutdown dragged into its third day.

Benzinga

Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio?

These ten large-cap stocks were the worst performers last week. Are they a part of your portfolio?

Barchart

Humana Stock: Is HUM Underperforming the Healthcare Sector?

While Humana has notably underperformed the broader healthcare sector over the past year, it has outperformed recently, and analysts remain optimistic about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Humana Stock?

While Humana stock seems to be regaining momentum lately, it is still underperforming the broader market, keeping analysts cautiously optimistic about its prospects.

Benzinga

Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments

As the healthcare landscape evolves with new legislation and shifting demographics, Humana Inc. (NYSE:HUM) is adapting to these changes through strategic adjustments. This adaptability is reflected in their second-quarter earnings report, which exceeded analysts’ expectations despite a decline in adjusted EPS compared to last year.

Benzinga

Humana Moves To Cut Prior Authorization Delays, Streamline Care Approvals

Humana Inc. NYSE: HUM) on Tuesday announced accelerated efforts to approve care requests as quickly as possible and reduce the administrative burden for physicians associated with prior authorization.

Benzinga

Humana Shares Decline After Losing Medicare Bonus Payment Lawsuit: What To Know

Shares of Humana Inc. (NYSE:HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.